YHB Investment Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.21M Buy
23,162
+751
+3% +$328K 0.59% 47
2026
Q1
$10.3M Buy
22,411
+174
+0.8% +$88K 0.74% 33
2025
Q4
$12.6M Buy
22,237
+194
+0.9% +$103K 0.87% 33
2025
Q3
$9.86M Buy
22,043
+62
+0.3% +$29.8K 0.72% 33
2025
Q2
$11.9M Buy
21,981
+210
+1% +$110K 0.92% 27
2025
Q1
$10.8M Sell
21,771
-169
-0.8% -$93.5K 0.9% 27
2024
Q4
$11.5M Sell
21,940
-56
-0.3% -$29.2K 0.94% 27
2024
Q3
$10.8M Sell
21,996
-763
-3% -$355K 0.89% 26
2024
Q2
$10.1M Sell
22,759
-104
-0.5% -$41.4K 0.87% 27
2024
Q1
$9.12M Buy
22,863
+60
+0.3% +$22.7K 0.81% 30
2023
Q4
$7.69M Sell
22,803
-5,960
-21% -$1.78M 0.74% 36
2023
Q3
$8.41M Sell
28,763
-492
-2% -$154K 0.78% 35
2023
Q2
$10M Sell
29,255
-113
-0.4% -$34.2K 0.93% 26
2023
Q1
$7.5M Buy
29,368
+205
+0.7% +$50.5K 0.75% 35
2022
Q4
$7.74M Sell
29,163
-210
-0.7% -$51.2K 0.83% 33
2022
Q3
$5.51M Buy
29,373
+31
+0.1% +$6.66K 0.61% 46
2022
Q2
$5.89M Buy
29,342
+220
+0.8% +$51.6K 0.62% 47
2022
Q1
$8.79M Sell
29,122
-1,786
-6% -$522K 0.78% 35
2021
Q4
$11.1M Buy
30,908
+152
+0.5% +$52.3K 0.88% 29
2021
Q3
$10.2M Sell
30,756
-129
-0.4% -$43.3K 0.88% 30
2021
Q2
$9.47M Buy
30,885
+33
+0.1% +$9.26K 0.81% 33
2021
Q1
$8.36M Buy
30,852
+693
+2% +$174K 0.72% 39
2020
Q4
$8.22M Sell
30,159
-615
-2% -$153K 0.78% 36
2020
Q3
$7.28M Sell
30,774
-4,407
-13% -$990K 0.79% 36
2020
Q2
$6.68M Buy
35,181
+465
+1% +$83.4K 0.96% 31
2020
Q1
$5.73M Buy
34,716
+480
+1% +$87.9K 0.99% 33
2019
Q4
$6.75M Sell
34,236
-921
-3% -$172K 0.96% 35
2019
Q3
$6.33M Buy
35,157
+1,833
+6% +$317K 0.97% 36
2019
Q2
$5.83M Sell
33,324
-489
-1% -$83.8K 0.93% 34
2019
Q1
$6.43M Sell
33,813
-678
-2% -$121K 1.01% 33
2018
Q4
$5.51M Buy
34,491
+3,711
+12% +$629K 0.98% 37
2018
Q3
$5.89M Sell
30,780
-1,875
-6% -$333K 0.89% 34
2018
Q2
$5.21M Buy
32,655
+135
+0.4% +$20.6K 0.85% 37
2018
Q1
$4.47M Buy
32,520
+1,113
+4% +$155K 0.76% 40
2017
Q4
$3.82M Sell
31,407
-615
-2% -$77K 0.65% 51
2017
Q3
$3.72M Sell
32,022
-4,563
-12% -$497K 0.67% 46
2017
Q2
$3.8M Buy
36,585
+4,473
+14% +$430K 0.65% 48
2017
Q1
$2.98M Buy
32,112
+585
+2% +$46.2K 0.57% 58
2016
Q4
$2.22M Sell
31,527
-324
-1% -$23.8K 0.46% 69
2016
Q3
$2.56M Sell
31,851
-396
-1% -$30.3K 0.62% 55
2016
Q2
$2.37M Sell
32,247
-315
-1% -$22.2K 0.52% 61
2016
Q1
$2.17M Buy
32,562
+720
+2% +$44.6K 0.59% 54
2015
Q4
$1.93M Sell
31,842
-1,890
-6% -$106K 0.44% 72
2015
Q3
$1.72M Sell
33,732
-270
-0.8% -$15.3K 0.41% 75
2015
Q2
$1.83M Buy
34,002
+765
+2% +$42.8K 0.4% 75
2015
Q1
$1.86M Buy
33,237
+423
+1% +$23.9K 0.42% 73
2014
Q4
$1.93M Sell
32,814
-783
-2% -$43.6K 0.44% 72
2014
Q3
$1.72M Sell
33,597
-945
-3% -$46.9K 0.41% 78
2014
Q2
$1.58M Buy
34,542
+1,800
+5% +$79.4K 0.38% 78
2014
Q1
$1.59M Sell
32,742
-900
-3% -$42.4K 0.4% 78
2013
Q4
$1.44M Sell
33,642
-918
-3% -$38.6K 0.39% 78
2013
Q3
$1.45M Buy
34,560
+252
+0.7% +$11.1K 0.43% 79
2013
Q2
$1.93M Buy
+34,308
New +$1.89M 0.6% 55

Other funds holding ISRG

YHB Investment Advisors's ISRG Position: Q2 2026 in Review

YHB Investment Advisors increased its Intuitive Surgical (ISRG) stake by 3.4% in Q2 2026, buying an estimated $328K and bringing the position to 23,162 shares worth $9.21M. The position accounts for 0.59% of the portfolio, ranked #47.

YHB Investment Advisors first reported a position in ISRG in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.6M in Q4 2025. 636 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • YHB Investment Advisors held 23,162 shares of Intuitive Surgical worth $9.21M as of Q2 2026.
  • YHB Investment Advisors bought 751 Intuitive Surgical shares in Q2 2026, an estimated $328K.
  • Intuitive Surgical made up 0.59% of YHB Investment Advisors's portfolio in Q2 2026, its #47 holding.
  • YHB Investment Advisors first reported a position in Intuitive Surgical in Q2 2013 and has held it in 53 quarters since.
  • YHB Investment Advisors's Intuitive Surgical position peaked at $12.6M in Q4 2025.
  • 636 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.